THORATEC CORPORATION | 24,905 Euro | +0,341 +1,39 % | |
| WKN: 867805 ISIN: US8851753074 Ticker-Symbol: TL1 | Frankfurt | 25.05.12 | 18:24 Uhr |
Branche GesundheitswesenAktienmarkt S&P MidCap 400 |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 22.05. | Thoratec Remains Neutral | - | Zacks | |
| 09.05. | Thoratec Presentation at Bank of America Merrill Lynch Health Care Conference to be Webcast | 11 | PR Newswire | |
| PLEASANTON, Calif., May 9, 2012 /PRNewswire/ --Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts... Mehr lesen zu: Thoratec Presentation at Bank of America Merrill Lynch Health Care Conference to be Webcast | ||||
| 03.05. | Why Thoratec's Earnings Are Outstanding | 1 | Motley Fool | |
| 02.05. | Thoratec Beats, Tweaks Forecast | - | Zacks | |
| 02.05. | Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 01.05. | Thoratec Reports First Quarter 2012 Results | 26 | PR Newswire | |
| PLEASANTON, Calif., May 1, 2012 /PRNewswire/ --Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and... Mehr lesen zu: Thoratec Reports First Quarter 2012 Results | ||||
| 24.04. | Thoratec Crosses Above its 10-day MA | - | SmarTrend | |
| 20.04. | Thoratec Schedules First Quarter Conference Call, Webcast | 23 | PR Newswire | |
| PLEASANTON, Calif., April 20, 2012 /PRNewswire/ --Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore... Mehr lesen zu: Thoratec Schedules First Quarter Conference Call, Webcast | ||||
| 17.04. | Thoratec Surpasses 10,000 HeartMate II® Implants Worldwide | 91 | PR Newswire | |
| PLEASANTON, Calif., April 17, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing... Mehr lesen zu: Thoratec Surpasses 10,000 HeartMate II® Implants Worldwide | ||||
| 05.04. | UPDATE 2-FDA issues recall on Thoratec HeartMate II pump | - | Reuters.com | |
| 04.04. | Thoratec (THOR) Sees No Material Impact from Voluntary Device Correction Notice on HeartMate II System | 1 | StreetInsider.com | |
| 04.04. | Thoratec Comments on February 23rd Voluntary Medical Device Correction Notification | 33 | PR Newswire | |
| PLEASANTON, Calif., April 4, 2012 /PRNewswire/ --Thoratec Corporation (Nasdaq: THOR) today commented on a recent voluntary medical device correction notification (the "Notification"), related to the... Mehr lesen zu: Thoratec Comments on February 23rd Voluntary Medical Device Correction Notification | ||||
| 04.04. | UPDATE 1-FDA issues recall on Thoratec HeartMate II pump | 2 | Reuters.com | |
| 04.04. | Shares of Thoratec Down on Above Average Volume, Moving Against Trend | - | SmarTrend | |
| 04.04. | Thoratec shares down following product recall | - | Reuters.com | |
| 12.03. | Thoratec Presentation at Barclays Healthcare Conference to be Webcast | 6 | PR Newswire | |
| PLEASANTON, Calif., March 12, 2012 /PRNewswire/ --Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore... Mehr lesen zu: Thoratec Presentation at Barclays Healthcare Conference to be Webcast | ||||
| 14.02. | Thoratec Presentation at Leerink Swann Healthcare Conference to be Webcast | 4 | PR Newswire | |
| PLEASANTON, Calif., Feb. 14, 2012 /PRNewswire/ --Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore... Mehr lesen zu: Thoratec Presentation at Leerink Swann Healthcare Conference to be Webcast | ||||
| 08.02. | UPDATE 1-Thoratec Q4 profit, FY outlook beats Street | 1 | Reuters.com | |
| 08.02. | Thoratec Reports Fourth Quarter and Full Year Fiscal 2011 Financial Results | 18 | PR Newswire | |
| PLEASANTON, Calif., Feb. 8, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts... Mehr lesen zu: Thoratec Reports Fourth Quarter and Full Year Fiscal 2011 Financial Results | ||||
| 26.01. | Thoratec Schedules Fourth Quarter Conference Call, Webcast | 6 | PR Newswire | |
| PLEASANTON, Calif., Jan. 25, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore... Mehr lesen zu: Thoratec Schedules Fourth Quarter Conference Call, Webcast | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
